Yilan T. Zeng
Huiming Road 211, China P.R
Chengdu, 611130, China
Chengdu, 611130, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Prognostic associations of vitamin D deficiency with disease severity, survival, and complications in alcohol-related liver disease.
Journal: Frontiers in medicine
Published: December 29, 2025
Carbon Ion Radiotherapy for Locally Advanced Pancreatic Cancer: A Systematic Review and Pooled Analysis of Single-arm Studies.
Journal: International journal of radiation oncology, biology, physics
Published: October 23, 2025
Machine learning prediction of rapid HBsAg seroclearance at week 24 in inactive carriers treated with pegylated interferon.
Journal: Hepatology international
Published: July 31, 2025
ASAP-12 Score Predicts HBsAg Seroclearance and Seroconversion in Chronic Hepatitis B Patients Receiving Peg-IFNα Add-On Therapy.
Journal: Journal of medical virology
Published: July 02, 2025
Characteristics and risk factors of drug-resistant tuberculosis in Sichuan, China: An observational study.
Journal: Tropical medicine & international health : TM & IH
Published: May 15, 2025
Peginterferon α-2b Enhances Hepatitis B Surface Antigen Loss in Nucleos(t)ide Analogue-Suppressed Low Hepatitis B Surface Antigen Chronic Hepatitis B Patients: Everest Study in China.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: February 19, 2025
Dynamic Changes of Growth and Thyroid Function in Young Children With Chronic Hepatitis B Treated With Peginterferon Monotherapy.
Journal: The Pediatric infectious disease journal
Published: September 30, 2024
Real-life study on the effectiveness and safety of sofosbuvir/velpatasvir-based antiviral agents for hepatitis C eradication in Chinese patients.
Journal: Journal of virus eradication
Published: July 29, 2024
Clinical, aetiological, and epidemiological studies of outpatient cases of hand, foot, and mouth disease in Chengdu, China, from 2019 to 2022: a retrospective study.
Journal: BMC public health
Published: January 24, 2024
Interim analysis of the PARADISE study: Benefits of add-on peginterferon-α in NA-treated patients with CHB.
Journal: Antiviral research
Published: January 09, 2024
TDF and TAF inhibit liver cancer cell migration, invasion via p7TP3.
Journal: Scientific reports
Published: November 17, 2023
Efficacy of pegylated interferon α-2b plus entecavir therapy and predictors of treatment success in children with chronic hepatitis B.
Journal: Frontiers in immunology
Published: August 25, 2023
Last Updated: 09/26/2026